Higher Scientific Officer - Assay Development and Compound Profiling

Higher Scientific Officer - Assay Development and Compound Profiling Key Information Salary : Commencement on the salary range is subject to comparableskills and experience. Reporting to : Dr Caroline Ewens Duration of Contract : Fixed Term for 18 months initially Hours per week : 35 hours per week (Full Time) Location : Sutton Closing Date : Sunday 8th February Under the guidance of Dr Caroline Ewens, we are seeking a highly motivated scientist keen to apply small molecule screening science expertise to help progress our cancer drug discovery projects from assay development and hit finding to candidate selection. The successful candidate will develop and run plate‑based biochemical and/or cellular screening assays to support the identification and characterisation of small‑molecule inhibitors against novel cancer targets using a variety of detection technologies. The successful candidate will be embedded in the Hit Discovery and Structural Design Team but work with multidisciplinary teams. About you Key requirements for the role are significant and broad all‑round laboratory experience monitoring small molecule binding and function applied to drug discovery. A good understanding of enzymology would be beneficial, as would prior use of automation equipment for liquid and compound handling used in compound profiling. Department/Directorate Information The Hit Discovery and Structural Design Team uses biochemical, cellular and biophysical assays to perform small‑molecule high‑throughput screening and fragment‑based hit discovery, coupled with X‑ray crystallography and electron microscopy to enable structure‑based drug design within the CCDD. These methodologies are underpinned by state‑of‑the‑art protein expression, purification and characterisation capabilities, allowing for the generation of large quantities of high‑quality protein targets. We are based at the ICR Sutton site in the newly opened CCDD building. Pertinent to this role, the team is equipped with high quality tissue culture suites and specialist screening equipment enabling access to numerous technology readouts. Our multimode plate readers include two Pherastars (BMG) and two Envisions (Perkin Elmer). Our biophysical technologies available include DSF/TSA (Nanotemper Prometheus & Biorad 384 well thermal cyclers) and SPR (GE Healthcare T200 & 8K Biacores). The team has access to high content screening microscopes (GE Incell 2200), whole well imaging cytometers (2 Nexcelom Celigos) and live cell imaging instruments (Sartorius Incucyte Zoom and S3). To enable fast and accurate assay preparation, the team possesses a broad range of liquid handling equipment, including pipetting robots, Certus Flex (Gyger), and two Beckman ECHO acoustic dispensing machines integrated onto Access systems for compound dispensing. You will be joining a team working at the crossroads of the drug discovery activities of the CCDD, where scientific excellence and team science are core values. This position will also offer training in new techniques and support will be available for attending training courses and appropriate academic meetings. What we offer A dynamic and supportive research environment Access to state‑of‑the‑art facilities and professional development opportunities Collaboration with leading researchers in the field Competitive salary and pension We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Dr Caroline Ewens via Email Caroline.Ewens@icr.ac.uk About The Institute of Cancer Research Why work for us? As a member of staff, you'll have exclusive access to a range of staff benefits. The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information. The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here. We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under‑represented within the ICR and nationwide in STEM roles. #J-18808-Ljbffr